Home/ Stocks/ KYNB

Kyntra Bio, Inc. Common Stock

KYNB XNAS

$7.27 +0.29 (+4.15%) ▲ 15-min delayed

Open

$6.97

High

$7.30

Low

$6.97

Volume

5.2K

Market Cap

$28.26M

About Kyntra Bio, Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 34 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$3.74M	$-15,198,000	$-3.76

Related Market News

No specific coverage for KYNB yet. Check out our latest market news or earnings calendar.

Get KYNB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kyntra Bio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.